120 related articles for article (PubMed ID: 3533676)
1. Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing.
Mukherjee PK; Davey A
J Int Med Res; 1986; 14(5):279-84. PubMed ID: 3533676
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of conventional and controlled-release formulations of trazodone in elderly depressed patients.
Bayer AJ; Pathy MS; Cameron A; Venkateswalu T; Ather SA; Mankikar GD; Ghosh AK
Clin Neuropharmacol; 1989; 12 Suppl 1():S50-5; Discussion S56-7. PubMed ID: 2663153
[TBL] [Abstract][Full Text] [Related]
3. Trazodone: alternative dose regimens and sleep.
Wheatley D
Pharmatherapeutica; 1984; 3(9):607-12. PubMed ID: 6374681
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy for depression with trazodone.
Fabre LF; Feighner JP
J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
[TBL] [Abstract][Full Text] [Related]
6. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline.
Blacker R; Shanks NJ; Chapman N; Davey A
Psychopharmacology (Berl); 1988; 95 Suppl():S18-24. PubMed ID: 3133708
[TBL] [Abstract][Full Text] [Related]
7. Trazodone. A comparative clinical and predictive study.
Kerr TA; McClelland HA; Stephens DA; Ankier SI
Acta Psychiatr Scand; 1984 Dec; 70(6):573-7. PubMed ID: 6395636
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two oral dosage regimens of 150 mg trazodone in the treatment of depression in general practice.
Davey A
Psychopharmacology (Berl); 1988; 95 Suppl():S25-30. PubMed ID: 3133709
[TBL] [Abstract][Full Text] [Related]
10. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
[TBL] [Abstract][Full Text] [Related]
12. Trazodone, a new antidepressant: efficacy and safety in endogenous depression.
Kellams JJ; Klapper MH; Small JG
J Clin Psychiatry; 1979 Sep; 40(9):390-5. PubMed ID: 383704
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
[TBL] [Abstract][Full Text] [Related]
14. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
16. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
[TBL] [Abstract][Full Text] [Related]
18. Trazodone and amitriptyline in treatment of depressed inpatients. A double-blind study.
Moises HW; Kasper S; Beckmann H
Pharmacopsychiatria; 1981 Sep; 14(5):167-71. PubMed ID: 7027279
[TBL] [Abstract][Full Text] [Related]
19. [Review of studies of trazodone at the Feighner Research Institute in ambulatory and hospitalized patients].
Feighner JP
Encephale; 1986 Oct; 12 Spec No():243-8. PubMed ID: 3816685
[TBL] [Abstract][Full Text] [Related]
20. Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin.
Altamura AC; Mauri MC; Colacurcio F; Scapicchio PL; Hadjchristos C; Carucci G; Minervini M; Montanini R; Perini M; Rudas N
Psychopharmacology (Berl); 1988; 95 Suppl():S34-6. PubMed ID: 3133712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
